Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Fanale

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
Haematologica|April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphomaPaolo Strati, Dai Chihara, Yasuhiro Oki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialJason R Westin, Michael A Thompson, Vince D Cataldo, et al.
British Journal of Haematology|July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphomaDai Chihara, Jason R Westin, Roberto N Miranda, et al.
British Journal of Haematology|July 23, 2016
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic modelYiming Chen, Sattva Neelapu, Lei Feng, et al.
British Journal of Haematology|August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphomaDai Chihara, Barbara Pro, Sanam Loghavi, et al.
British Journal of Haematology|December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphomaJay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
Head & Neck|April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
Haematologica|April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphomaPaolo Strati, Dai Chihara, Yasuhiro Oki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialJason R Westin, Michael A Thompson, Vince D Cataldo, et al.
British Journal of Haematology|July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphomaDai Chihara, Jason R Westin, Roberto N Miranda, et al.
British Journal of Haematology|July 23, 2016
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic modelYiming Chen, Sattva Neelapu, Lei Feng, et al.
British Journal of Haematology|August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphomaDai Chihara, Barbara Pro, Sanam Loghavi, et al.
British Journal of Haematology|December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphomaJay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
Head & Neck|April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Pageof 9